192 related articles for article (PubMed ID: 5125050)
1. [Preliminary results of the use of amantadine in parkinsonian syndromes].
Montanari M; Monaco V; Robotti CA
Minerva Med; 1971 Oct; 62(82):3955-7. PubMed ID: 5125050
[No Abstract] [Full Text] [Related]
2. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa].
Ambrosetto C; Martinelli P
Minerva Med; 1971 Oct; 62(82):4017-9. PubMed ID: 5125069
[No Abstract] [Full Text] [Related]
3. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes].
Kluzer G; Lampo B
Minerva Med; 1971 Oct; 62(82):4013-4. PubMed ID: 5125067
[No Abstract] [Full Text] [Related]
4. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes and their implications for rehabilitation].
Raspa EG; Paciaroni E; Saccomanno G
Minerva Med; 1971 Oct; 62(82):4031-5. PubMed ID: 5125073
[No Abstract] [Full Text] [Related]
5. [Current medical treatment of Parkinsonian syndromes].
Cincă I; Bulandra R; Serbănesco A; Ninosu N
Rev Roum Neurol; 1973; 10(4):257-85. PubMed ID: 4767886
[No Abstract] [Full Text] [Related]
6. [Preliminary psychological findings during treatment of the parkinsonian syndrome with amantadine. Preliminary observations].
Barbieri NF; Megna GF; Micalizzi V; Pigneri MT; Puca FM
Minerva Med; 1971 Oct; 62(82):4000-3. PubMed ID: 5125063
[No Abstract] [Full Text] [Related]
7. [Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes].
Ciuca I; Bulandra R; Serbanesco A; Ninosu N
Rev Neurol (Paris); 1972 Aug; 127(2):305-8. PubMed ID: 4672049
[No Abstract] [Full Text] [Related]
8. [The addition of amantadine to prolonged treatment with L-Dopa. Considerations on 20 cases].
Giuffrè R; Gambacorta D
Minerva Med; 1971 Oct; 62(82):4009-12. PubMed ID: 5125066
[No Abstract] [Full Text] [Related]
9. [Effects induced by the treatment with amantadine on habituation of trigemino-facial reflexes in Parkinsonian patients].
Messina C; Tomasello F
Riv Neurol; 1972; 42(2):202-8. PubMed ID: 4341955
[No Abstract] [Full Text] [Related]
10. The treatment of parkinsonism with L-Dopa and amantadine.
Green J
J Fla Med Assoc; 1970 Jun; 57(6):28-33. PubMed ID: 5445813
[No Abstract] [Full Text] [Related]
11. L-dopa and amantadine hydrochloride in Parkinson's disease.
Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
[No Abstract] [Full Text] [Related]
12. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
Sigwald J; Raymondeaud C; Piot C
Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
[No Abstract] [Full Text] [Related]
13. [6 months of treatment with amantadine and L-Dopa. Comparison in 2 groups of patients with parkinsonism].
Buscaino GA; Campanella G; Zallone E
Minerva Med; 1971 Oct; 62(82):3974-8. PubMed ID: 5125057
[No Abstract] [Full Text] [Related]
14. [The treatment of parkinsonism with amantadine].
Völler GW
Dtsch Med Wochenschr; 1970 Apr; 95(17):934-7. PubMed ID: 5439551
[No Abstract] [Full Text] [Related]
15. [Amantadine hydrochloride in the treatment of Parkinson's syndrome].
De la Herrán J; Figuerido JA
Rev Esp Otoneurooftalmol Neurocir; 1971; 29(167):45-9. PubMed ID: 5091472
[No Abstract] [Full Text] [Related]
16. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
Hacohen H; Gurtner B
Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377
[No Abstract] [Full Text] [Related]
17. Amantadine hydrochloride in treatment of Parkinsonism.
Nagaswami S; Nagaswami R
Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
[No Abstract] [Full Text] [Related]
18. Levodopa and amantadine in the treatment of Parkinsonism.
Critchley E
Practitioner; 1972 Apr; 208(246):499-504. PubMed ID: 5031037
[No Abstract] [Full Text] [Related]
19. [Treatment of the Parkinson syndrome with amantadine].
Hartmann-von Monakow K
Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
[No Abstract] [Full Text] [Related]
20. [The therapeutic association of L-dopa and amantadine. Preliminary results in a group of patients with Parkinson's disease].
Gomirato G; Perfetti C
Riv Neurobiol; 1970; 16(3):247-54. PubMed ID: 5518838
[No Abstract] [Full Text] [Related]
[Next] [New Search]
